Hep A Vaccine May Provide 30 Years of Protection
LONDON - Researchers studying the lasting effects of GlaxoSmithKline's hepatitis A vaccine Havrix say the inoculation may provide 30 years, rather than 10 years, of protection.
Following 155 adults who were vaccinated with Havrix in 1990, the team followed a mathematical formula to determine the protective antibody levels in those vaccinated would remain persistent for 20 to 30 years.
Hepatitis A infection can be contracted by contaminated water or food. Any region of the world without proper sanitation or running water is considered high risk. The virus can cause fever, malaise, jaundice, liver failure and death.
The results of the study were presented at the tenth International Congress on Infectious Diseases in Singapore.
Information from www.givenimaging.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
